Microbot Medical Inc. investors report an 8.2% beneficial stake in the company’s common stock. The filing is a Schedule 13G submitted jointly by Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC. As of the close of business on January 23, 2026, they report beneficial ownership of 6,002,185 shares of common stock, all issuable upon exercise of a warrant held by Intracoastal. This stake is calculated as approximately 8.2% of the common stock, based on 67,158,044 shares outstanding as of November 14, 2025 plus the warrant shares. The reporting persons have shared, but not sole, voting and dispositive power over these shares and certify they do not hold the securities for the purpose of changing or influencing control of the issuer.
Positive
None.
Negative
None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G filing disclose about Microbot Medical (MBOT)?
The Schedule 13G shows that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC together report beneficial ownership of 6,002,185 shares of Microbot Medical common stock through a warrant.
What percentage of Microbot Medical (MBOT) does the reporting group beneficially own?
The reporting persons state that the 6,002,185 shares issuable upon exercise of the Intracoastal warrant represent approximately 8.2% of Microbot Medical’s common stock.
How is the 8.2% ownership stake in Microbot Medical (MBOT) calculated?
The 8.2% figure is based on 67,158,044 shares of common stock outstanding as of November 14, 2025, plus 6,002,185 shares of common stock issuable upon exercise of the Intracoastal warrant.
Do the reporting persons have sole or shared voting power over Microbot Medical (MBOT) shares?
Each reporting person reports 0 shares with sole voting or dispositive power and 6,002,185 shares with shared voting and shared dispositive power related to the warrant shares.
Are the Microbot Medical (MBOT) securities held to influence control of the company?
The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing the control of Microbot Medical, other than in connection with certain nomination activities referenced in the certification.
Who are the entities behind the 8.2% beneficial ownership in Microbot Medical (MBOT)?
The filing is made on behalf of Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC, a Delaware limited liability company that holds the warrant for 6,002,185 shares.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Microbot Medical Inc.
(Name of Issuer)
Common stock, par value $0.01 per share
(Title of Class of Securities)
59503A204
(CUSIP Number)
01/15/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
59503A204
1
Names of Reporting Persons
Mitchell P. Kopin
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,002,185.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,002,185.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,002,185.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.2 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP No.
59503A204
1
Names of Reporting Persons
Daniel B. Asher
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,002,185.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,002,185.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,002,185.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.2 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP No.
59503A204
1
Names of Reporting Persons
Intracoastal Capital LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,002,185.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,002,185.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,002,185.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Microbot Medical Inc.
(b)
Address of issuer's principal executive offices:
175 Derby St., Bld. 27, Hingham, MA 02043
Item 2.
(a)
Name of person filing:
This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)
Address or principal business office or, if none, residence:
The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)
Citizenship:
Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)
Title of class of securities:
Common stock, par value $0.01 per share
(e)
CUSIP No.:
59503A204
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on January 23, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 6,002,185 shares of Common Stock issuable upon exercise a warrant held by Intracoastal (the "Intracoastal Warrant") and all such shares of Common Stock represented beneficial ownership of approximately 8.2% of the Common Stock, based on (1) 67,158,044 shares of Common Stock outstanding as of November 14, 2025, as reported by the Issuer, plus (2) 6,002,185 shares of Common Stock issuable upon exercise of the Intracoastal Warrant.
(b)
Percent of class:
8.2%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
6,002,185
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
6,002,185
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
